World's Best Scientists 2026 revealed!
Award Badge
Immunology
Iran
2026

D-Index & Metrics

Immunology

D-Index
54
Citations
9691
World Ranking
3900
National Ranking
3

Gholamreza Azizi publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Gholamreza Azizi sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 251 publications — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Gholamreza Azizi D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Gholamreza Azizi sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 54 D-Index — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in Iran Leader Award
  • 2025 - Research.com Immunology in Iran Leader Award

Overview

Gholamreza Azizi is affiliated with Alborz University of Medical Sciences in Iran. Their research primarily spans the fields of Immunology and Microbiology, Medicine, and Biochemistry, Genetics, and Molecular Biology. The subfields of focus include Immunology, Genetics, Molecular Biology, Infectious Diseases, and Oncology.

The research topics covered by Azizi extensively involve Immunodeficiency and Autoimmune Disorders, Blood disorders and treatments, Immune Cell Function and Interaction, T-cell and B-cell Immunology, Immunotherapy and Immune Responses, Cystic Fibrosis Research Advances, and Congenital Ear and Nasal Anomalies.

Azizi has published several papers in notable venues, including:

  • Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis and management, 2020, Scandinavian Journal of Immunology
  • Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment, 2022, Frontiers in Immunology
  • Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach, 2022, International Immunopharmacology
  • CDK1 in Breast Cancer: Implications for Theranostic Potential, 2020, Anti-Cancer Agents in Medicinal Chemistry
  • Global systematic review of primary immunodeficiency registries, 2020, Expert Review of Clinical Immunology

Their frequent publication venues include:

  • Endocrine Metabolic & Immune Disorders - Drug Targets
  • International Immunopharmacology
  • Journal of Clinical Immunology
  • Frontiers in Immunology
  • Pediatric Allergy and Immunology

Azizi collaborates regularly with several co-authors, notably:

  • Hassan Abolhassani
  • Reza Yazdani
  • Asghar Aghamohammadi
  • Samaneh Delavari
  • Nima Rezaei

Best Publications

  • Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis and management.

    Abubakar Umar Anka;Mohammed Ibrahim Tahir;Sharafudeen Dahiru Abubakar;Mohamed Alsabbagh

  • The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer.

    Ali Masjedi;Vida Hashemi;Mohammad Hojjat-Farsangi;Ghasem Ghalamfarsa

  • Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach

    Unknown

  • Primary immunodeficiency and autoimmunity: A comprehensive review.

    Laura Amaya-Uribe;Manuel Rojas;Gholamreza Azizi;Juan Manuel Anaya

  • The paradox of Th17 cell functions in tumor immunity.

    Zahra Asadzadeh;Hamed Mohammadi;Elham Safarzadeh;Maryam Hemmatzadeh

  • Selective IgA Deficiency: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management

    Reza Yazdani;Reza Yazdani;Reza Yazdani;Gholamreza Azizi;Hassan Abolhassani;Hassan Abolhassani;Asghar Aghamohammadi

  • A role for Th1-like Th17 cells in the pathogenesis of inflammatory and autoimmune disorders.

    Ali N. Kamali;Seyedeh Masoomeh Noorbakhsh;Haleh Hamedifar;Farhad Jadidi-Niaragh

  • Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritis

    Gholamreza Azizi;Farhad Jadidi-Niaragh;Abbas Mirshafiey

  • The effects of cadmium exposure in the induction of inflammation.

    Nikoo Hossein-Khannazer;Gholamreza Azizi;Solat Eslami;Hussaini Alhassan Mohammed

  • Clinical, Immunological, and Genetic Features in Patients with Activated PI3Kδ Syndrome (APDS): a Systematic Review.

    Mahnaz Jamee;Shakiba Moniri;Majid Zaki-Dizaji;Majid Zaki-Dizaji;Peter Olbrich

  • CD73 as a potential opportunity for cancer immunotherapy

    Ghasem Ghalamfarsa;Mohammad Hossein Kazemi;Sahar Raoofi Mohseni;Ali Masjedi

  • Common Variable Immunodeficiency: Epidemiology, Pathogenesis, Clinical Manifestations, Diagnosis, Classification, and Management

    Reza Yazdani;S. Habibi;L. Sharifi;Gholamreza Azizi

  • The Role of Different Subsets of Regulatory T Cells in Immunopathogenesis of Rheumatoid Arthritis

    Maryam Gol-Ara;Farhad Jadidi-Niaragh;Reza Sadria;Gholamreza Azizi

  • Global systematic review of primary immunodeficiency registries.

    Hassan Abolhassani;Hassan Abolhassani;Gholamreza Azizi;Laleh Sharifi;Reza Yazdani

  • Clinical, Immunologic, and Molecular Spectrum of Patients with LPS-Responsive Beige-Like Anchor Protein Deficiency: A Systematic Review.

    Sima Habibi;Majid Zaki-Dizaji;Hosein Rafiemanesh;Bernice Lo

  • Autoimmunity in common variable immunodeficiency: epidemiology, pathophysiology and management.

    Gholamreza Azizi;Hassan Abolhassani;Mohammad Hosein Asgardoon;Tina Alinia

  • Fourth Update on the Iranian National Registry of Primary Immunodeficiencies: Integration of Molecular Diagnosis

    Hassan Abolhassani;Hassan Abolhassani;Hassan Abolhassani;Fatemeh Kiaee;Fatemeh Kiaee;Marzieh Tavakol;Zahra Chavoshzadeh

  • The Potential Role of Chemokines in Alzheimer's Disease Pathogenesis

    Gholamreza Azizi;Nikoo Khannazer;Abbas Mirshafiey

  • The potential role of proinflammatory and antiinflammatory cytokines in Alzheimer disease pathogenesis.

    Gholamreza Azizi;Abbas Mirshafiey

  • Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer.

    Vahid Karpisheh;Afshin Nikkhoo;Mohammad Hojjat-Farsangi;Mohammad Hojjat-Farsangi;Afshin Namdar

  • The significance of matrix metalloproteinases in the immunopathogenesis and treatment of multiple sclerosis.

    Abbas Mirshafiey;Babak Asghari;Ghasem Ghalamfarsa;Farhad Jadidi-Niaragh

  • The hyper IgM syndromes: Epidemiology, pathogenesis, clinical manifestations, diagnosis and management.

    Reza Yazdani;Saba Fekrvand;Sepideh Shahkarami;Gholamreza Azizi

  • Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells.

    Farnaz Hajizadeh;Isobel Okoye;Maryam Esmaily;Mitra Ghasemi Chaleshtari

Frequent Co-Authors

Asghar Aghamohammadi
Asghar Aghamohammadi Tehran University of Medical Sciences
Nima Rezaei
Nima Rezaei Tehran University of Medical Sciences
Abbas Mirshafiey
Abbas Mirshafiey Tehran University of Medical Sciences
Farhad Jadidi-Niaragh
Farhad Jadidi-Niaragh Tabriz University of Medical Sciences
Lennart Hammarström
Lennart Hammarström Karolinska Institute
Behzad Baradaran
Behzad Baradaran Tabriz University of Medical Sciences
Bahman Yousefi
Bahman Yousefi Tabriz University of Medical Sciences
Juan-Manuel Anaya
Juan-Manuel Anaya Universidad del Rosario
Alessandro Plebani
Alessandro Plebani University of Brescia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology in the USA, exploring related fields can open diverse career opportunities, especially in healthcare. Many students consider advancing their education through specialized nursing programs. There are options like the cheapest psychiatric nurse practitioner programs that combine affordability with comprehensive training, making them attractive to those seeking cost-effective paths.

Career advancement in nursing often correlates with competitive salaries, and salary can vary widely depending on the state. Understanding the dnp salary by state can help plan long-term goals and choose where to practice. This insight is valuable for Immunology graduates considering a Doctor of Nursing Practice (DNP) degree.

Some nurses choose to specialize further by gaining certifications like the acute care np certification, which equips them for more intensive patient care environments. This transition reflects the dynamic nature of healthcare careers related to Immunology and nursing.

For accelerated educational routes, many students look into accelerated fnp programs. These allow qualified candidates to quickly advance their credentials and enter the workforce with Family Nurse Practitioner expertise, complementing Immunology backgrounds with clinical nursing skills.

Best Scientists Citing Gholamreza Azizi

Trending Scientists

Recently Published Articles